Centrally Acting ACE Inhibition in SLE
Centrally Acting ACE Inhibition in SLE
Active, not recruiting · NCT04486118 · Registry updated 2025-09-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Centrally Acting ACE Inhibition in SLE | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Active, not recruiting | Phase 2 | 2025-09-19 | NCT04486118 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lupus Research Alliance | 4 |
| Northwell Health | 107 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Albert Einstein College of Medicine | The Bronx | United States | 25 |
| Andrew Shaw | Manhasset | United States | 1 |
| Columbia University Medical center | New York | United States | 224 |
| Hospital for Special Surgery | New York | United States | 1 |
| New York University School of Medicine | New York | United States | 22 |
| Northwell Rheumatology | Great Neck | United States | 1 |
| Yale University School of Medicine | New Haven | United States | 17 |